Drugs

-Fetoprotein and -Human Chorionic Gonadotropin: Their Clinical Significance as Tumour Markers
pp. 463-467(5)
Authors: Gregory J.J.J.; Finlay J.L.

Host Defence (Cationic) Peptides: What Is Their Future Clinical Potential?
pp. 469-473(5)
Author: Hancock R.E.W.

Cardiotoxicity of the Antiproliferative Compound Fluorouracil
pp. 475-484(10)
Authors: Becker K.; Erckenbrecht J.F.; Häaussinger D.; Frieling T.

Current Drug Therapy for Multiple Myeloma
pp. 485-506(22)
Authors: Huang Y-W.; Hamilton A.; Arnuk O.J.; Chaftari P.; Chemaly R.

Systematic Review and Guide to Selection of Selective Serotonin Reuptake Inhibitors
pp. 507-533(27)
Authors: Edwards J.G.; Anderson I.

Treatment of Epilepsy in Pregnancy
pp. 535-544(10)
Authors: Nulman I.; Laslo D.; Koren G.

Current Guidelines for the Treatment of Patients with Rheumatic Fever
pp. 545-555(11)
Authors: Thatai D.; Turi Z.G.

Finasteride: An Update of its Use in the Management of Symptomatic Benign Prostatic Hyperplasia
pp. 557-581(25)
Authors: Wilde M.I.; Goa K.L.

Fluvastatin: A Review of its Use in Lipid Disorders
pp. 583-606(24)
Authors: Langtry H.D.; Markham A.

Mirtazapine: A Review of its Use in Major Depression
pp. 607-631(25)
Authors: Holm K.J.; Markham A.

Nebivolol in the Management of Essential Hypertension: A Review
pp. 633-651(19)
Authors: McNeely W.; Goa K.L.